Biofil Chemicals & Pharmaceuticals Ltd. | Small-cap | Healthcare
₹40.26
-1.23%
| Biofil Chemicals Stock Comparison:
Biofil Chemicals vs Sun PharmaceuticalBiofil Chemicals vs Divi's LaboratoriesBiofil Chemicals vs Innova CaptabBiofil Chemicals vs Suven Life SciencesBiofil Chemicals vs Gujarat ThemisBiofil Chemicals vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 64.3M
Gross Profit 4.4M 6.89%
Operating Income -602.0K -0.94%
Net Income 24.1M 37.48%
EPS (Diluted) ₹1.48

Balance Sheet Metrics

Total Assets 509.6M
Total Liabilities 321.8M
Shareholders Equity 187.8M
Debt to Equity 1.71

Cash Flow Metrics

Revenue & Profitability Trend

Biofil Chemicals Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i334.0M400.4M300.4M223.8M357.5M
Cost of Goods Sold i308.5M375.1M274.2M194.6M324.3M
Gross Profit i25.6M25.3M26.1M29.2M33.2M
Gross Margin % i7.7%6.3%8.7%13.1%9.3%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i1.9M1.5M1.5M2.0M1.9M
Other Operating Expenses i7.3M8.9M6.7M5.8M6.3M
Total Operating Expenses i9.2M10.4M8.2M7.7M8.1M
Operating Income i4.7M4.2M7.4M9.0M11.9M
Operating Margin % i1.4%1.0%2.5%4.0%3.3%
Non-Operating Items
Interest Income i442.0K67.0K16.0K210.0K214.0K
Interest Expense i361.0K395.0K419.0K390.0K642.0K
Other Non-Operating Income-----
Pre-tax Income i7.4M8.7M7.9M10.1M19.2M
Income Tax i1.8M1.6M2.3M3.2M6.8M
Effective Tax Rate % i24.2%18.0%29.3%31.2%35.3%
Net Income i5.6M7.1M5.6M7.0M12.4M
Net Margin % i1.7%1.8%1.9%3.1%3.5%
Key Metrics
EBITDA i11.5M13.0M12.6M14.9M21.2M
EPS (Basic) i₹0.34₹0.44₹0.34₹0.44₹0.77
EPS (Diluted) i₹0.34₹0.44₹0.34₹0.44₹0.77
Basic Shares Outstanding i1627380016273800162738001627380016273800
Diluted Shares Outstanding i1627380016273800162738001627380016273800

Income Statement Trend

Biofil Chemicals Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i2.6M22.8M377.0K1.4M4.4M
Short-term Investments i1.2M21.9M117.0K600.0K4.3M
Accounts Receivable i383.2M330.3M205.0M71.7M172.2M
Inventory i33.4M25.5M12.1M12.9M43.4M
Other Current Assets420.0K264.0K2.4M2.5M10.8M
Total Current Assets i425.5M384.1M223.5M93.1M234.6M
Non-Current Assets
Property, Plant & Equipment i2.4M2.4M2.4M2.4M2.4M
Goodwill i-----
Intangible Assets i-----
Long-term Investments-----
Other Non-Current Assets620.0K-1.0K-1.0K-1.0K-
Total Non-Current Assets i84.1M86.8M90.5M94.2M97.8M
Total Assets i509.6M470.8M314.1M187.3M332.4M
Liabilities
Current Liabilities
Accounts Payable i309.9M275.5M126.5M6.0M158.5M
Short-term Debt i4.7M4.4M5.2M4.6M4.3M
Current Portion of Long-term Debt-----
Other Current Liabilities1.0K1.0K-30.0K-1.0K-
Total Current Liabilities i318.5M285.2M137.3M14.9M167.5M
Non-Current Liabilities
Long-term Debt i-----
Deferred Tax Liabilities i3.3M3.6M3.8M4.0M3.6M
Other Non-Current Liabilities1.0K---1.0K-
Total Non-Current Liabilities i3.3M3.6M3.8M4.0M3.6M
Total Liabilities i321.8M288.8M141.0M18.9M171.1M
Equity
Common Stock i162.7M162.7M162.7M162.7M162.7M
Retained Earnings i-311.2M-316.9M-326.0M-330.6M-337.7M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i187.8M182.0M173.0M168.4M161.3M
Key Metrics
Total Debt i4.7M4.4M5.2M4.6M4.3M
Working Capital i107.1M98.8M86.3M78.2M67.1M

Balance Sheet Composition

Biofil Chemicals Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i7.4M8.7M7.9M10.1M19.2M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-63.5M-138.5M-131.0M138.6M94.5M
Operating Cash Flow i-55.8M-129.5M-122.7M149.1M114.4M
Investing Activities
Capital Expenditures i-1.0M-229.0K-106.0K-699.0K-961.0K
Acquisitions i-----
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-1.0M-229.0K-106.0K-699.0K-961.0K
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i-----
Debt Repayment i-----
Financing Cash Flow i324.0K82.6M576.0K348.0K-
Free Cash Flow i-20.2M23.7M-1.2M-2.9M5.4M
Net Change in Cash i-56.5M-47.1M-122.2M148.8M113.4M

Cash Flow Trend

Biofil Chemicals Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 23.70
Price to Book 3.61
Price to Sales 1.95
PEG Ratio 0.02

Profitability Ratios

Profit Margin 8.19%
Operating Margin 31.74%
Return on Equity 2.97%
Return on Assets 1.09%

Financial Health

Current Ratio 1.34
Debt to Equity 2.51
Beta 0.97

Per Share Data

EPS (TTM) ₹1.72
Book Value per Share ₹11.29
Revenue per Share ₹21.05

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
biofilchem657.1M23.703.612.97%8.19%2.51
Sun Pharmaceutical 4.0T37.735.4215.08%19.29%3.26
Divi's Laboratories 1.7T70.6110.8514.64%23.89%0.03
Innova Captab 47.4B36.474.9413.37%9.98%35.24
Suven Life Sciences 48.0B-28.3141.36-146.15%84.44%0.00
Gujarat Themis 44.7B100.6418.1919.64%30.17%12.27

Financial data is updated regularly. All figures are in the company's reporting currency.